4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-HYDROXYETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
Compound with spectra: 1 NMR
![4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-HYDROXYETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID](/api/compound/LkBgQQZZTCD.png?ph=true&h=300&w=458 "4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-HYDROXYETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID")
| SpectraBase Compound ID | LkBgQQZZTCD |
|---|---|
| InChI | InChI=1S/C19H28N4O5S/c1-22-16-6-5-13(11-15(16)21-17(22)3-2-4-18(25)26)23(7-9-24)8-10-29-12-14(20)19(27)28/h5-6,11,14,24H,2-4,7-10,12,20H2,1H3,(H,25,26)(H,27,28)/t14-/m0/s1 |
| InChIKey | DZJFLXGFUNUDNU-AWEZNQCLSA-N |
| Mol Weight | 424.52 g/mol |
| Molecular Formula | C19H28N4O5S |
| Exact Mass | 424.178041 g/mol |
| Enantiomer InChIKey | DZJFLXGFUNUDNU-CQSZACIVSA-N |
| Racemate InChIKey | DZJFLXGFUNUDNU-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
4-[5-[BIS-[2-(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-CHLOROETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
#8;4-[5-[[2-(2-ACETYLAMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-[2-(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
4-[5-[BIS-[2-(2-ACETYLAMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
3-pyridinecarboxamide, N-[3-[5-(acetylamino)-1-methyl-1H-benzimidazol-2-yl]propyl]-6-chloro-
2-furancarboxamide, tetrahydro-N-[2-[1-methyl-5-[(2-methyl-1-oxopropyl)amino]-1H-benzimidazol-2-yl]ethyl]-
2-furancarboxamide, tetrahydro-N-[2-[1-methyl-5-[(3-methyl-1-oxobutyl)amino]-1H-benzimidazol-2-yl]ethyl]-
N-{2-[1-methyl-5-(pentanoylamino)-1H-benzimidazol-2-yl]ethyl}-2-furamide
2-furancarboxamide, N-[2-[5-(benzoylamino)-1-methyl-1H-benzimidazol-2-yl]ethyl]tetrahydro-
benzamide, N-[2-[5-(acetylamino)-1-methyl-1H-benzimidazol-2-yl]ethyl]-3-chloro-4-fluoro-
| Title | Journal or Book | Year |
|---|---|---|
| SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA | Drug Metabolism and Disposition | 2005 |